U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income -4.39M -5.09M -5.15M -5.20M -5.48M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 36.30K 45.40K 54.50K 63.60K 36.40K
Total Other Non-Cash Items 1.65M 2.08M 2.15M 2.21M 1.96M
Change in Net Operating Assets -144.20K 121.50K 97.50K 435.20K 770.10K
Cash from Operations -2.85M -2.84M -2.85M -2.49M -2.71M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 2.01M 2.39M 2.81M 2.47M 1.40M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 2.00M 0.00 0.00 0.00 35.00K
Cash from Financing 4.01M 2.39M 2.81M 2.47M 1.44M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.16M -452.70K -39.70K -20.70K -1.27M
Weiss Ratings